The Endocrine and Reproductive System: Adverse Effects of Hormonally Active Substances?

Pediatrics

Volumn 113, Issue 4 II, 2004, Pages 1070-1075

  Greim, Helmut A ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Adverse effects; Endocrine disrupters; Phytoestrogens; Test systems; Xenoestrogens

Indexed keywords

DAIDZEIN; ENDOCRINE DISRUPTOR; ENVIRONMENTAL CHEMICAL; ESTRADIOL; GENISTEIN; HORMONE; HORMONE RECEPTOR AFFECTING AGENT; ISOFLAVONE; PHYTOESTROGEN; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

ADOLESCENT; ARTIFICIAL MILK; BIOASSAY; CHILD; DIET; DISEASE ASSOCIATION; DRUG POTENCY; EMBRYO; ENDOCRINE DISEASE; ENVIRONMENTAL EXPOSURE; FETUS; HERSHBERGER ASSAY; HORMONE ACTION; HORMONE LIKE EFFECT; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFANT; INFANT NUTRITION; NEWBORN; NONHUMAN; PERINATAL PERIOD; PRENATAL EXPOSURE; PRIORITY JOURNAL; REPRODUCTIVE TOXICITY; REVIEW; RISK ASSESSMENT; SOYBEAN; TOXICITY TESTING; UTEROTROPHIC ASSAY;

ANIMALS; BIOLOGICAL ASSAY; ENDOCRINE SYSTEM; ESTROGENS, NON-STEROIDAL; FEMALE; HAZARDOUS SUBSTANCES; HUMANS; ISOFLAVONES; MALE; PHENOLS; PHYTOESTROGENS; PLANT PREPARATIONS; PREGNANCY; REPRODUCTION; TOXICITY TESTS; UROGENITAL SYSTEM; XENOBIOTICS;

EID: 1842586812     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Colborn T, Dumanoski D, Myers JP. Our Stolen Future: Are We Threatening Our Fertility, Intelligence, and Survival? A Scientific Detective Story. New York, NY: Dutton; 1996
2. Carlsen E, Giwercman A, Keiding N, Skakkebaek NE. Evidence for decreasing quality of semen during past 50 years. Br Med J. 1993;305: 609-613
3. Sharpe RM, Skakkebaek NE. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet. 1993;341: 1392-1395
4. Colborn T, vom Saal FS, Soto AM. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect. 1993;101:378-384
5. Barlow S, Kavlock RJ, Moore JA, et al. Teratology Society Public Affairs Committee position paper: developmental toxicity of endocrine disruptors to humans. Teratology. 1999;60:365-375
6. Combes RD. Endocrine disruptors - a critical review of in vitro and in vivo testing strategies for assessing their toxic hazard to humans. Altern Lab Anim. 2000;28:81-118
7. Scientific Committee for Toxicity, Ecotoxicity and the Environment. CSTEE Opinion on human and wildlife health effects of endocrine disrupting chemicals, with emphasis on wildlife and on ecotoxicology test methods. European Commission, DG XXIV, Consumer Policy and Consumer Health Protection; March 1999. Available at: www.europa.eu.int/comm/dg24/health/sc/sct/outcome/en.html
8. Degen GH, Bolt HM. Endocrine disruptors: update on xenoestrogens. Int Arch Occup Environ Health. 2000;73:433-441
9. Goldman JM, Laws SC, Balchak SK, Cooper RL, Kavlock RJ. Endocrine-disrupting chemicals: prepubertal exposures and effects on sexual maturation and thyroid activity in the female rat. A focus on the EDSTAC recommendations. Crit Rev Toxicol. 2000;30:135-196
10. Mendes JJA. The endocrine disrupters: a major medical challenge. Fd Chem Toxicol. 2002;40:781-788
11. National Research Council. Hormonally Active Agents in the Environment. Washington, DC: National Academy Press; 1999
12. Nilsson R. Endocrine modulators in the food chain and environment. Toxicol Pathol. 2000;28:420-431
13. Safe SH. Endocrine disruptors and human health - is there a problem? An update. Environ Health Perspect. 2000;108:487-493
14. Vos JG, Dybing E, Greim H, et al. Health effects of endocrine-disrupting chemicals on wildlife, with special reference to the European situation. Crit Rev Toxicol. 2000;30:71-133
15. Kimmel CA, Makris SL. Recent developments in regulatory requirements for developmental toxicology. Toxicol Lett. 2001;120:73-82
16. Schmidt CW. NIHS News. The low down on low-dose endocrine disruptors. Environ Health Perspect. 2001;109:A420-A421
17. Garry VF, Harkins ME, Erickson LL, Long-Simpson LK, Holland SE, Burroughs BL. Birth defects, season of conception, and sex of children born to pesticide applicators living in the Red River Valley of Minnesota, USA. Environ Health Perspect. 2002;110(suppl 3):441-449
18. Guillette EA. A broad-based evaluation of pesticide-exposed children. Cent Eur J Public Health. 2000;8:58-89
19. Skakkebaek NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod. 2001;16:972-978
20. Sultan C, Paris F, Terouanne B, et al. Disorders linked to insufficient androgen action in male children. Hum Reprod Update. 2001;7:314-322
21. Aoki Y. Polychlorinated biphenyls, polychlorinated dibenzo-p-dioxins, and polychlorinated dibenzofurans as endocrine disrupters - what we have learned from Yusho disease? Environ Res. 2001;86:2-11
22. Longnecker MP, Kiebanoff MA, Zhou H, Brock JW. Association between maternal serum concentration of the DDT metabolite DDE and preterm and small-for-gestational-age babies at birth. Lancet. 2001;358: 110-114
23. Martuzzi M, DiTanno ND, Bertollini R. Declining trends of male proportion at birth in Europe. Arch Environ Health. 2001;56:358-364
24. International Programme on Chemical Safety (IPCS). Report of IPCS/OECD scoping meeting on endocrine disruptors (EDCs). Washington, DC; March 1998. Available at: www.endocrine.ei.jrc.it/IPCS_March98.rtf
25. ECETOC (European Centre for Ecotoxicology and Toxicology of Chemicals). Environmental Oestrogens: A Compendium of Test Methods. Brussels, Belgium: ECETOC; 1996 (ECETOC document no. 33)
26. Eisenbrand G, ed. Hormonally Active Agents in Food. Symposium organized by the DFG Senate Commission on the Evaluation of Food Safety. Weinheim: VCH-Wiley; 1998
27. Foster WG. Endocrine disruptors and development of the reproductive system in the fetus and children: is there cause for concern? Can J Public Health. 1998;89(suppl 1):S37-S41, S52, S41-S46
28. Routledge EJ, Sumpter JP. Estrogenic activity of surfactants and some of their degradation products assessed using a recombinant yeast screen. Environ Toxicol Chem. 1996;15:241-248
29. Soto AM, Sonnenschein C, Chung KL, Fernandez MF, Olea N, Serrano MF. The E-screen assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ Health Perspect. 1995; 103(suppl 7):113-122
30. Nakagawa Y, Suzuki T. Metabolism of 2-hydroxy-4-methoxybenzophenone in isolated rat hepatocytes and xenoestrogenic effects of its metabolites on MCF-7 human breast cancer cells. Chem Biol Interact. 2002; 139:115-128
31. O'Reilly JM, Li N, Duax WL, Brueggemeier RW. Synthesis, structure elucidation, and biochemical evaluation of 7α- and 7β -arylaliphatic-substituted androst-4-ene-3,17-diones as inhibitors of aromatase. J Med Chem. 1995;8:2842-2850
32. Kuhnz W, Beier S. Comparative progestational and androgenic activity of norgestimate and levonorgestrel in the rat. Contraception. 1994;49: 275-289
33. Odum J, Lefevre PA, Tittensor S, et al. The rodent uterotrophic assay: critical protocol features, studies with nonyl phenols, and comparison with a yeast estrogenicity assay. Regul Toxicol Pharmacol. 1997;25:176-188
34. Organisation for Economic Co-operation and Development (OECD). Guidance Document for the Development of OECD Guidelines for Testing of Chemicals. Paris, France: OECD; 1993 (reformatted 1995)
35. Sonnenschein C, Soto AM, Fernandez MF, Olea N, Olea-Serrano MF, Ruiz-Lopez MD. Development of a marker of estrogenic exposure in human serum. Clin Chem. 1996;41:1888-1895
36. Safe SH. Environmental and dietary estrogens and human health: is there a problem? Environ Health Perspect. 1995;103:346-351
37. Bolt HM, Janning P, Michna H, Degen GH. Comparative assessment of endocrine modulators with oestrogenic activity: I. Definition of a hygiene-based margin of safety (HBMOS) for xeno-oestrogens against the background of European developments. Arch Toxicol. 2001;74:649-662
38. Degen GH, Janning P, Diel P, Michna H, Bolt HM. Transplacental transfer of the phytoestrogen daidzein in DA/Han rats. Arch Toxicol. 2002;76:23-29
39. Setchell KDR, Zimmer-Nechemias L, Cai J, Heubi JE. Isoflavone content of infant formulas and the metabolic fate of these phytoestrogens in early life. Am J Clin Nutr. 1998;68:1453S-1461S
40. vom Saal FS, Cooke PS, Buchanan DL, et al. A physiologically based approach to the study of bisphenol A and other estrogenic chemicals on the size of reproductive organs, daily sperm production, and behavior. Toxicol Ind Health. 1998;14:239-260
41. Nagel SC, vom Saal FS, Thayer KA, Dhar MG, Boechler M, Welshons WV. Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol. Environ Health Perspect. 1997;105:70-76
42. Tyl RW, Myers CB, Marr MC, et al. Three-generation reproductive toxicity study of dietary bisphenol A in CD Sprague-Dawley rats. Toxicol Sci. 2002;68:121-146
43. Arnold SF, Klotz DM, Collins BM, Vonier PM, Guillette LJ Jr, McLachlan JA. Synergistic activation of estrogen receptor with combinations of environmental chemicals. Science. 1996;272:1489-1492
44. Gaido KW, McDonnell DP, Korach KS, Safe SH. Estrogen activity of chemical mixtures: is there synergism? CIIT Activities. 1997;17:1-7
45. McLachlan JA. Synergistic effect of environmental estrogens: report withdrawn. Science. 1997;277:462-463
46. Cassidy A. Physiological effects of phyto-estrogens in relation to cancer and other human health risks. Proc Nutr Soc. 1996;55:399-417
47. Setchell KDR, Zimmer-Nechemias L, Cai J, Heubi JE. Exposure of infants to phyto-estrogens from soy-based infant formula. Lancet. 1997; 350:23-27
48. Cassidy A, Bingham S, Setchell K. Biological effects of isoflavones in young women: importance of the chemical composition of soyabean products. Br J Nutr. 1995;74:587-601
49. Tham DM, Gardner CD, Haskell WL. Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J Clin Endocrinol Metab. 1998;83:2232-2235
50. Essex C. Phytoestrogens and soy based infant formula. Br Med J. 1996; 313:507-508
51. GDCh-Advisory Committee on Existing Chemicals (Beratergremium für Altstoffe: BUA). Report 228: Biological Impact of Synthetic and Natural Endocrine Active Substances - Effects on Human Health. Stuttgart, Germany: Hirzel Verlag; 2002
52. Damstra T, Barlow S, Bergman A, Kavlock R, Van Der Kraak G, eds. International Programme on Chemical Safety (IPCS). Global Assessment of the State-of-the-Science of Endocrine Disruptors. Geneva, Switzerland: World Health Organization; 2002